Newest
PEBO ▼ sold $76K · Augenstein Mark filed 1d agoBBT ▲ bought $105K · Hollister Thomas J filed 2d agoBBT ▼ sold $20K · Eagan John Buckley filed 2d agoGS ▼ sold $60K · LESLIE ERICKA T filed 2d agoGS ▼ sold $163K · LESLIE ERICKA T filed 2d agoMSCI ▼ sold $1.5M · Gutowski Robert J. filed 2d agoGL ▼ sold $2.2M · MAJORS MICHAEL CLAY filed 2d agoPHR ▲ bought $362 · Linetsky David filed 2d agoPHR ▲ bought $320 · Linetsky David filed 2d agoRVI ▲ bought $23K · Whitney Meredith filed 2d agoLEO ▲ bought $369K · Saba Capital Management, L.P. filed 2d agoPG ▼ sold $5.7M · Jejurikar Shailesh filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoICLR ▼ sold $15K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoPG ▼ sold $698K · Gama Paul filed 2d ago

Insider / NXP Semiconductors N.V.

Olving Lena

Director at NXP Semiconductors N.V.

Company
NXP Semiconductors N.V.
Ticker
NXPI
First filing on record
June 12, 2026
Latest trade on record
June 10, 2026
SEC filings
EDGAR ↗

Olving Lena, Director at NXP Semiconductors N.V., has disclosed 4 transactions in NXPI since June 12, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $153K at the reported prices. The latest was filed June 12, 2026, 2 days after the trade.

Last updated June 12, 2026 · Source: SEC EDGAR Form 4 filings

Transactions
4
Open-market buys
0
Sales
1
Avg. disclosure lag
2.0d

Trading in charts

Trade timeline

When does this person trade, how big, and in which direction? Every trade in the last 12 months.

Bought (above the line)Sold (below the line)Other transaction
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep

In the last 12 months Olving Lena made no purchases and 1 sale worth $153K, plus 3 other transactions. Dot size is the dollar amount.

Portfolio mix

Which stocks does this person trade most? Tile size is dollars traded, all time on record.

Olving Lena has traded 1 stock on record; the largest by dollars is NXPI.

What kind of transactions

Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.

Rows by Form 4 transaction code
CodeMeaningRowsSharesValue
MOption exercise or conversion22,070—
AGrant or award1841—
FShares withheld for tax1513$153K
Rows by year of the trade
YearRowsBoughtSold
2026401 · $153K

Transactions

Download NXPI trades (CSV)150 rows · 52 KB · every filer in this ticker, this insider included · all downloads

SecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
NXPIOther AJune 10, 2026June 12, 20262d841——derivativeForm 4 ↗
NXPIOption / conversion MJune 10, 2026June 12, 20262d1,035——derivativeForm 4 ↗
NXPISell FJune 10, 2026June 12, 20262d513$297$153KForm 4 ↗
NXPIOption / conversion MJune 10, 2026June 12, 20262d1,035——Form 4 ↗

Filings

FiledFormAccessionRowsStatusSource
June 12, 2026Form 40001781889-26-0000024publishedEDGAR ↗

Other insiders at NXP Semiconductors N.V.

Everyone on file, with contracts and lobbying under the company's name: NXP Semiconductors N.V..

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 414June 12, 2026June 12, 2026Form 4 list on EDGAR

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.